Regulation of T cell receptor δ gene rearrangement by CBF/PEBP2

Journal of Experimental Medicine

Volumn 185, Issue 7, 1997, Pages 1193-1201

  Lauzurica, Pilar ^a,b   Zhong, Xiao Ping ^a   Krangel, Michael S ^a   Roberts, Joseph L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR;

ARTICLE; GENE CONTROL; GENE LOCUS; GENE REARRANGEMENT; GENETIC ANALYSIS; IMMUNOREGULATION; MOUSE; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; T LYMPHOCYTE RECEPTOR GENE; TRANSGENIC MOUSE;

ANIMALS; BINDING SITES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REARRANGEMENT, DELTA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; MICE; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS;

EID: 0030984563     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.7.1193     Document Type: Article

References (59)

1. Alt, F.W., T.K. Blackwell, and G.D. Yancopoulos. 1987. Development of the primary antibody repertoire. Science (Wash. DC). 238:1079-1087.
2. Alt, F.W., E.M. Oltz, F. Young, J. Gorman, G. Taccioli, and J. Chen. 1992. VDJ recombination. Immunol. Today. 13: 306-314.
3. Schatz, D.G., M.A. Oettinger, and M.S. Schlissel. 1992. V(D)J recombination: molecular biology and regulation. Annu. Rev. Immunol. 10:359-383.
4. Lewis, S.M. 1994. The mechanism of V(D)J joining: lessons from molecular, immunological and comparative analyses. Adv. Immunol. 56:27-150.
5. Sleckman, B.P., J.R. Gorman, and F.W. Alt. 1996. Accessibility control of antigen receptor variable region gene assembly: role of cis-acting elements. Annu. Rev. Immunol. 14: 459-481.
6. Fowlkes, B.J., and D.M. Pardoll. 1989. Molecular and cellular events of T cell development. Adv. Immunol. 44:207-264.
7. Staudt, L.M., and M.J. Lenardo. 1991. Immunoglobulin gene transcription. Annu. Rev. Immunol. 9:373-398.
8. Leiden, J.M. 1993. Transcriptional regulation of T cell receptor genes. Annu. Rev. Immunol. 11:539-570.
9. Ferrier, P., B. Krippl, T.K. Blackwell, A.J.W. Furley, H. Suh, A. Winoto, W.D. Cook, L. Hood, F. Costantini, and F.W. Alt. 1990. Separate elements control DJ and VDJ rearrangement in a transgenic recombination substrate. EMBO (Eur. Mol. Biol. Organ.) J. 9:117-125.
10. Lauster, R., C.-A. Reynaud, I.-L. Martensson, A. Peter, D. Bucchini, J. Jami, and J.-C. Weill. 1993. Promoter, enhancer and silencer elements regulate rearrangement of an immunoglobulin transgene. EMBO (Eur. Mol. Biol. Organ.) J. 12: 4615-4623.
11. Kallenbach, S., C. Babinet, S. Pournin, P. Cavelier, M. Goodhardt, and F. Rougeon. 1993. The intronic immunoglobulin κ gene enhancer acts independently on rearrangement and on transcription. Eur. J. Immunol. 23:1917-1921.
12. Capone, M., F. Watrin, C. Fernex, B. Horvat, B. Krippl, L. Wu, R. Scollay, and P. Ferrier. 1993. TCRβ and TCRα gene enhancers confer tissue-and stage-specificity on V(D)J recombination events. EMBO (Eur. Mol. Biol. Organ.) J. 12: 4335-4346.
13. Lauzurica, P., and M.S. Krangel. 1994. Enhancer-dependent and -independent steps in the rearrangement of a human T cell receptor δ transgene. J. Exp. Med. 179:43-55.
14. Lauzurica, P., and M.S. Krangel. 1994. Temporal and lineage-specific control of T cell receptor α/δ gene rearrangement by T cell receptor α and δ enhancers. J. Exp. Med. 179: 1913-1921.
15. Okada, A., M. Mendelsohn, and F. Alt. 1994. Differential activation of transcription versus recombination of transgenic T cell receptor β variable region gene segments in B and T lineage cells. J. Exp. Med. 180:261-272.
16. Fernex, C., M. Capone, and P. Ferrier. 1995. The V(D)J recombinational and transcriptional activities of the immunoglobulin heavy-chain intronic enhancer can be mediated through distinct protein-binding sites in a transgenic substrate. Mol. Cell. Biol. 15:3217-3226.
17. Chen, J., F. Young, A. Bottaro, V. Stewart, R.K. Smith, and F.W. Alt. 1993. Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus. EMBO (Eur. Mol. Biol. Organ.) J. 12:4635-4645.
18. Takeda, S., Y.-R. Zou, H. Bluethmann, D. Kitamura, U. Muller, and K. Rajewsky. 1993. Deletion of the immunoglobulin kappa chain intron enhancer abolishes kappa chain gene rearrangement in cis but not lambda chain gene rearangement in trans. EMBO (Eur. Mol. Biol. Organ.) J. 12: 2329-2336.
19. Serwe, M., and F. Sablitzky. 1993. V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer. EMBO (Eur. Mol. Biol. Organ.) J. 12:2321-2327.
20. Gorman, J.R., N. van der Stoep, R. Monroe, M. Cogne, L. Davidson, and F.W. Alt. 1996.The IgK 3′ enhancer influences the ration of Igκ versus Igλ B lymphocytes. Immunity. 5: 241-252.
21. Xu, Y., L. Davidson, F.W. Alt, and D. Baltimore. 1996. Deletion of the Igκ light chain intronic enhancer/matrix attachment region impairs but does not abolish VκJκ rearrangement. Immunity. 4:377-385.
22. Bories, J.-C., J. Demengeot, L. Davidson, and F.W. Alt. 1996. Gene-targeted deletion and replacement of the T-cell receptor β-chain enhancer: the role of enhancer elements in controlling V(D)J recombination accessibility. Proc. Natl. Acad. Sci. USA. 93:7871-7876.
23. Bouvier, G., F. Watrin, M. Naspetti, C. Verthuy, P. Naquet, and P. Ferrier. 1996. Deletion of the mouse T-cell receptor β gene enhancer blocks αβ T-cell development. Proc. Natl. Acad. Sci. USA. 93:7877-7881.
24. Redondo, J.M., S. Hata, C. Brocklehurst, and M.S. Krangel. 1990. A T cell specific transcriptional enhancer within the human T cell receptor δ locus. Science (Wash. DC). 247: 1225-1229.
25. Redondo, J.M., J.L. Pfohl, and M.S. Krangel. 1991. Identification of an essential site for transcriptional activation within the human T cell receptor δ enhancer. Mol. Cell. Biol. 11: 5671-5680.
26. Redondo, J.M., J.L. Pfohl, C. Hernandez-Munain, S. Wang, N.A. Speck, and M.S. Krangel. 1992. Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor δ and murine leukemia virus enhancers. Mol. Cell. Biol. 12:4817-4823.
27. Hernandez-Munain, C., and M.S. Krangel. 1994. Regulation of the T-cell receptor δ enhancer by functional cooperation between c-Myb and core-binding factors. Mol. Cell. Biol. 14: 473-483.
28. Hernandez-Munain, C., and M.S. Krangel. 1995. c-Myb and core-binding factor (CBF/PEBP2) display functional synergy but bind independently to adjacent sites in the TCR δ enhancer. Mol. Cell. Biol. 15:3090-3099.
29. Wang, S., Q. Wang, B.E. Crute, I.N. Melnikova, S.R. Keller, and N.A. Speck. 1993. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Mol. Cell. Biol. 13:3324-3339.
30. Ogawa, E., M. Maruyama, H. Kagoshima, I. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ito. 1993. PEBP2/PEA2 represents a new family of transcription factor homologous to the products of the Drosophila runt and the human AML1. Proc. Natl. Acad. Sci. USA. 90:6859-6863.
31. Ogawa, E., M. Inuzuka, M. Maruyama, M. Satake, M. Naito-Fujimoto, Y. Ito, and K. Shigesada. 1993. Molecular cloning and characterization of PEBP2β, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2α. Virol. 194:314-331.
32. Shen-Ong, G.L.C. 1990. The myb oncogene. Biochim. Biophys. Acta. 1032:39-52.
33. Prosser, H.M., D. Wotton, A. Gegonne, J. Ghysdael, S. Wang, N.A. Speck, and M.J. Owen. 1992. A phorbol ester response element within the human T-cell receptor β-chain enhancer. Proc. Natl. Acad. Sci. USA. 89:9934-9938.
34. Hsiang, Y.H., D. Spencer, S. Wang, N.A. Speck, and D.H. Raulet. 1993. The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-γ and -δ gene expression. J. Immunol. 150:3905-3916.
35. Wotton, D., J. Ghysdael, S. Wang, N.A. Speck, and M.J. Owen. 1994. Cooperative binding of Ets-1 and core binding factor to DNA. Mol. Cell. Biol. 14:840-850.
36. Giese, K., C. Kingsley, J.R. Kirshner, and R. Grosschedl. 1995. Assembly and function of a TCRα enhancer complex is dependent on LEF-1-induced DNA bending and mutliple protein-protein interactions. Genes Dev. 9:995-1008.
37. Okuda, T., J. van Deursen, S.W. Hiebert, G. Grosveld, and J.R. Downing. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:321-330.
38. Ho, S.N., H.D. Hunt, R.M. Horton, J.K. Pullen, and L.R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene (Amst.). 77:51-59.
39. Hernandez-Munain, C., P. Lauzurica, and M.S. Krangel. 1996. Regulation of T cell receptor δ gene rearrangement by c-Myb. J. Exp. Med. 183:289-293.
40. Joulin, V., D. Bories, J.-F. Eleouet, M.-C. Labasteie, S. Chretien, M.-G. Mattei, and P.H. Romeo. 1991. A T-cell specific TCR δ DNA binding protein is a member of the human GATA family. EMBO (Eur. Mol. Biol. Organ.) J. 10: 1809-1816.
41. Marine, J., and A. Winoto. 1991. The human enhancer-binding protein Gata3 binds to several T-cell receptor regulatory elements. Proc. Natl. Acad. Sci. USA. 88:7284-7288.
42. Kamachi, Y., E. Ogawa, M. Asano, S. Ishida, Y. Murakami, M. Satake, Y. Ito, and K. Shigesada. 1990. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J. Virol. 64:4808-4819.
43. Wang, S., and N.A. Speck. 1992. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Mol. Cell. Biol. 12:89-102.
44. Suzow, J., and A.D. Friedman. 1993. The murine myeloperoxidase promoter contains several functional elements, one of which binds a cell type-restricted transcription factor, myeloid nuclear factor 1 (MyNF1). Mol. Cell. Biol. 13:2141-2151.
45. Nuchprayoon, I., S. Meyers, L.M. Scott, J. Suzow, S. Hiebert, and A.D. Friedman. 1994. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2β/CBFβ proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol. Cell. Biol. 14:5558-5568.
46. Zhang, D.-E., K.-I. Fujioka, C.J. Hetherington, L.H. Shapiro, H.-M. Chen, A.T. Look, and G.T. Tenen. 1994. Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol. Cell. Biol. 14:8085-8095.
47. Cameron, S., D.S. Taylor, E.C. TePas, N.A. Speck, and B. Mathey-Prevot. 1994. Identification of a critical regulatory site in the human interleukin-3 promoter by in vivo foot-printing. Blood. 83:2851-2859.
48. Takahashi, A., M. Satake, Y. Yamaguchi-Iwai, S.-C. Bae, J. Lu, M. Maruyama, Y.W. Zhang, H. Oka, N. Arai, K. Aria et al. 1995. Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. Blood. 86:607-616.
49. Bae, S.C., Y. Yamaguchi-Iwai, E. Ogawa, M. Maruyama, M. Inuzuka, H. Kagoshima, K. Shigesada, M. Satake, and Y. Ito. 1993. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene. 8:809-814.
50. Levanon, D., V. Negreanu, Y. Bernstein, I. Bar-Am, L. Avivi, and Y. Groner. 1994. AML1, AML2, and AML3, the human members of the runt domain gene family: cDNA structure, expression, and chromosomal localization. Genomics. 23:425-432.
51. Bae, S.-C., E. Takahashi, Y.W. Zhang, E. Ogawa, K. Shigesada, Y. Namba, M. Satake, and Y. Ito. 1995. Cloning, mapping and expression of PEBP2αC, a third gene encoding the mammalian Runt domain. Gene (Amst.). 159:245-248.
52. Wijmenga, C., N.A. Speck, N.C. Dracopoli, M.H. Hofker, P. Liu, and F.S. Collins. 1995. Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the human homolog, CBFA3, to chromosome 1p35-pter. Genomics. 26:611-614.
53. Bae, S.-C., E. Ogawa, M. Maruyama, H. Oka, M. Satake, K. Shigesada, N.A. Jenkins, D.J. Gilbert, N.G. Copeland, and Y. Ito. 1994. PEBP2 B/mouse AML1 consist of multiple isoforms that possess differential transactivation potentials. Mol. Cell. Biol. 14:3242-3252.
54. Chien, Y.-H., M. Iwashima, D.A. Wettstein, K.B. Kaplan, J.F. Elliot, W. Born, and M.M. Davis. 1987. T-cell receptor δ gene rearrangements in early thymocytes. Nature (Lond.). 330:722-727.
55. Wilson, A., W. Held, and H.R. MacDonald. 1994. Two waves of recombinase gene expression in developing thymocytes. J. Exp. Med. 179:1355-1360.
56. Satake, M., S. Nomura, Y. Yamaguchi-Iwai, Y. Takahama, Y. Hashimoto, M. Niki, Y. Kitamura, and Y. Ito. 1995. Expression of the runt domain-encoding PEBP2α genes in T cells during thymic development. Mol. Cell Biol. 15:1662-1670.
57. Forrester, W.C., C. van Genderen, T. Jenuwein, and R. Grosschedl. 1994. Dependence of enhancer-mediated transcription of the immunoglobulin μ gene on nuclear matrix attachment regions. Science (Wash. DC). 265:1221-1225.
58. Aronow, B.J., R.N. Silbiger, M.R. Dusing, J.L. Stock, K.L. Yager, S.S. Potter, J.J. Hutton, and D.A. Wiginton. 1992. Functional analysis of the human adenosine deaminase gene thymic regulatory region and its ability to generate position-independent transgene expression. Mol. Cell. Biol. 12:4170-4185.
59. Aronow, B.J., C.A. Ebert, M.T. Valerius, S.S. Potter, D.A. Wiginton, D.P. Witte, and J.J. Hutton. 1995. Dissecting a locus control region: facilitation of enhancer function by extended enhancer-flanking sequences. Mol. Cell. Biol. 15:1123-1135.